|
🐢
|
Vascular Endothelial Growth Factor in Predicting Outcome in Breast Cancer
P. Krippl,
U. Langsenlehner,
H. Samonigg,
W. Renner,
H. Köppel
|
8 |
2004 |
8
🐢
|
|
🐜
|
Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk
9 auth.
U. Langsenlehner,
P. Krippl,
W. Renner,
B. Yazdani-Biuki,
T. Eder,
H. Köppel,
...
T. Wascher,
B. Paulweber,
H. Samonigg
|
6 |
2005 |
6
🐜
|
|
🐜
|
Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.
8 auth.
Wilfried Renner,
H. Köppel,
Christine Hoffmann,
Katharina Schallmoser,
Olaf Stanger,
Hermann Toplak,
...
T. C. Wascher,
E. Pilger
|
6 |
2000 |
6
🐜
|
|
🐜
|
The 5A/6A Polymorphism of the Matrix Metalloproteinase 3 Gene Promoter and Breast Cancer
9 auth.
P. Krippl,
U. Langsenlehner,
W. Renner,
B. Yazdani-Biuki,
H. Köppel,
A. Leithner,
...
T. Wascher,
B. Paulweber,
H. Samonigg
|
5 |
2004 |
5
🐜
|
|
🐜
|
The fibrinogen gamma (FGG) 10034C>T polymorphism is associated with venous thrombosis.
8 auth.
G. Grünbacher,
W. Weger,
E. Marx-Neuhold,
E. Pilger,
H. Köppel,
T. Wascher,
...
W. März,
W. Renner
|
5 |
2007 |
5
🐜
|
|
🐬
|
Re: Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma.
P. Krippl,
U. Langsenlehner,
W. Renner,
H. Köppel,
H. Samonigg
|
5 |
2004 |
5
🐬
|
|
🐬
|
G‐455A polymorphism of the fibrinogen beta gene and deep vein thrombosis
W. Renner,
L. Cichocki,
A. Forjanics,
H. Köppel,
R. Gasser,
E. Pilger
|
5 |
2002 |
5
🐬
|
|
🐜
|
Factor II G20210A and Factor V G1691A Gene Mutations and Peripheral Arterial Occlusive Disease
8 auth.
W. Renner,
H. Köppel,
M. Brodmann,
E. Pabst,
K. Schallmoser,
H. Toplak,
...
T. Wascher,
E. Pilger
|
5 |
2000 |
5
🐜
|
|
🐜
|
The serotonin transporter gene polymorphism is not associated with smoking behavior
11 auth.
Olivia Trummer,
H. Köppel,
T. C. Wascher,
G. Grünbacher,
M. Gutjahr,
O. Stanger,
...
S. Ramschak-Schwarzer,
Bernhard O. Boehm,
B. Winkelmann,
Winfried März,
Wilfried Renner
|
4 |
2006 |
4
🐜
|
